4.6 Article

Prenatal testosterone excess alters Sertoli and germ cell number and testicular FSH receptor expression in rams

Journal

Publisher

AMER PHYSIOLOGICAL SOC
DOI: 10.1152/ajpendo.00032.2010

Keywords

fetal programming; follicle-stimulating hormone

Funding

  1. Fondecyt [1050915]
  2. DFG GZ [444 113/7/0-1]

Ask authors/readers for more resources

Exposure to excess testosterone (T) during fetal life has a profound impact on the metabolic and reproductive functions in the female's postnatal life. However, less is known about the effects of excess testosterone in males. The aim of the present study was to evaluate the impact (consequences) of an excess of T during fetal development on mature male testis. The testicular evaluation was by histological analysis and by determination of mRNA expression of the FSH receptor (FSH-R), transforming growth factor-beta type I receptor (T beta R-I), and two members of the TGF-beta superfamily, transforming growth factor-beta 3 (TGF beta 3) and anti-Mullerian hormone (AMH) in males born to mothers receiving an excess of T during pregnancy. At 42 wk of age, postpubertal males born to mothers treated with 30 mg of T propionate twice weekly from day 30 to 90, followed by 40 mg of T propionate from day 90 to 120 of pregnancy (T males), showed higher concentrations of FSH in response to a GnRH analog, a higher number of Sertoli cells/seminiferous tubule cross-section, and a lower number of germ cells/tubules (P < 0.05) than control males (C males) born to mothers treated with the vehicle. The mRNA expression of FSH-R and of T beta R-I was higher in T males compared with C males (P < 0.05). Moreover, in T males, AMH expression level correlated negatively with the expression level of TGF beta 3. In C males, this latter correlation was not observed. These results suggest that prenatal exposure to an excess of T can negatively modify some histological and molecular characteristics of the mature testis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Editorial Material Endocrinology & Metabolism

Noncanonical Wnt Signaling in the Integrity of the Blood-Testis Barrier and Sperm Release Comment

Rodolfo A. Rey

ENDOCRINOLOGY (2021)

Article Endocrinology & Metabolism

Gonadectomy in conditions affecting sex development: a registry-based cohort study

Angela K. Lucas-Herald, Jillian Bryce, Andreas Kyriakou, Marie Lindhardt Ljubicic, Wiebke Arlt, Laura Audi, Antonio Balsamo, Federico Baronio, Silvano Bertelloni, Markus Bettendorf, Antonia Brooke, Hedi L. Claahsen van der Grinten, Justin H. Davies, Gloria Hermann, Liat de Vries, Ieuan A. Hughes, Rieko Tadokoro-Cuccaro, Feyza Darendeliler, Sukran Poyrazoglu, Mona Ellaithi, Olcay Evliyaoglu, Simone Fica, Lavinia Nedelea, Aneta Gawlik, Evgenia Globa, Nataliya Zelinska, Tulay Guran, Ayla Guven, Sabine E. Hannema, Olaf Hiort, Paul-Martin Holterhus, Violeta Iotova, Vilhelm Mladenov, Vandana Jain, Rajni Sharma, Farida Jennane, Colin Johnston, Gil Guerra Junior, Daniel Konrad, Odile Gaisl, Nils Krone, Ruth Krone, Katherine Lachlan, Dejun Li, Corina Lichiardopol, Lidka Lisa, Renata Markosyan, Inas Mazen, Klaus Mohnike, Marek Niedziela, Anna Nordenstrom, Rodolfo Rey, Mars Skaeil, Lloyd J. W. Tack, Jeremy Tomlinson, Naomi Weintrob, Martine Cools, S. Faisal Ahmed

Summary: This study examined trends in clinical practice for individuals with DSD requiring gonadectomy and found that the likelihood of gonadectomy depends on the underlying diagnosis, sex of rearing, and geographical setting. Variations in the practice of gonadectomy were observed among different countries.

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2021)

Review Developmental Biology

AMH and AMHR2 Involvement in Congenital Disorders of Sex Development

Franco G. Brunello, Rodolfo A. Rey

Summary: Anti-mullerian hormone (AMH) is crucial for male fetal genital development, with its deficiency potentially leading to abnormalities. Defects in the AMH pathway, resulting in Persistent Mullerian Duct Syndrome, cause a rare condition where patients have male external genitalia but also internal female reproductive organs.

SEXUAL DEVELOPMENT (2022)

Editorial Material Endocrinology & Metabolism

Genetics of reproductive endocrinology Preface

Rodolfo A. Rey

BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2022)

Article Endocrinology & Metabolism

Growth, puberty and testicular function in boys born small for gestational age with a nonspecific disorder of sex development

Lloyd J. W. Tack, Saskia van der Straaten, Stefan Riedl, Alexander Springer, Paul-Martin Holterhus, Nadine C. Hornig, Zofia Kolesinska, Marek Niedziela, Federico Baronio, Antonio Balsamo, Sabine E. Hannema, Anna Nordenstrom, Sukran Poyrazoglu, Fatma F. Darendeliler, Romina Grinspon, Rodolfo Rey, Fahad Aljuraibah, Jillian Bryce, Faisal Ahmed, Rieko Tadokoro-Cuccaro, Ieuan Hughes, Guilherme Guaragna-Filho, Andrea T. Maciel-Guerra, Gil Guerra-Junior, Martine Cools

Summary: The study found that almost one out of three SGA boys experience insufficient catch-up growth by the age of 2. Additionally, SGA boys had higher LH levels during minipuberty and lower testosterone levels in stimulation tests.

CLINICAL ENDOCRINOLOGY (2022)

Review Endocrinology & Metabolism

Up-to-Date Clinical and Biochemical Workup of the Child and the Adolescent with a Suspected Disorder of Sex Development

Romina P. Grinspon, Sebastian Castro, Rodolfo A. Rey

Summary: In this review, we present a practical and updated approach to clinical and hormonal laboratory workup for newborns, children, and adolescents with suspected DSD. We emphasize the importance of tailoring the diagnostic approach based on age and presentation.

HORMONE RESEARCH IN PAEDIATRICS (2023)

Review Endocrinology & Metabolism

Recent advancement in the treatment of boys and adolescents with hypogonadism

Rodolfo A. Rey

Summary: Clinical manifestations and treatment needs of hypogonadism in males vary according to age. Early onset hypogonadism may result in disorders of sex development, while hypogonadism established later in fetal life presents with micropenis, cryptorchidism, and/or micro-orchidism. Diagnosis of hypogonadism becomes challenging after neonatal activation of the gonadal axis diminishes. Treatment usually focuses on micropenis and/or cryptorchidism in infancy and childhood, and on lack of pubertal development and relative short stature in teenagers.

THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM (2022)

Editorial Material Endocrinology & Metabolism

Next-Generation Sequencing as First-Line Diagnostic Test in Patients With Disorders of Sex Development?

Rodolfo A. Rey

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2022)

Article Pediatrics

Delayed Puberty Due to a WDR11 Truncation at Its N-Terminal Domain Leading to a Mild Form of Ciliopathy Presenting With Dissociated Central Hypogonadism: Case Report

Sebastian Castro, Franco G. Brunello, Gabriela Sanso, Paula Scaglia, Maria Esnaola Azcoiti, Agustin Izquierdo, Florencia Villegas, Ignacio Bergada, Maria Gabriela Ropelato, Marcelo A. Marti, Rodolfo A. Rey, Romina P. Grinspon

Summary: Pubertal delay in males can be caused by constitutional delay of growth and puberty or pathologic hypogonadism. Central (or hypogonadotropic) hypogonadism, resulting from a defective function of the GnRH/gonadotropin axis, is the main differential diagnosis after ruling out general illnesses and primary testicular failure. Ciliopathies arising from defects in non-motile cilia can cause developmental disorders affecting the sense organs and reproductive system.

FRONTIERS IN PEDIATRICS (2022)

Review Endocrinology & Metabolism

AMH Regulation by Steroids in the Mammalian Testis: Underlying Mechanisms and Clinical Implications

Nadia Y. Edelsztein, Clara Valeri, Maria M. Lovaisa, Helena F. Schteingart, Rodolfo A. Rey

Summary: Anti-Mullerian hormone (AMH) is a biomarker of immature Sertoli cells, which is regulated by specific transcription factors and plays a role in the regression of Mullerian ducts in males. AMH is highly expressed before puberty and then downregulated. FSH increases AMH output, while intratesticular levels of androgens and estrogens also regulate AMH secretion.

FRONTIERS IN ENDOCRINOLOGY (2022)

Article Pharmacology & Pharmacy

Considerations when treating male pubertal delay pharmacologically

Rodolfo A. Rey

Summary: This review discusses the etiologies and specific pharmacological therapies for delayed puberty in males. There is limited high-quality evidence available for the best pharmacological therapy approach, with most current practice based on small case series or unpublished experience. Medical treatment is likely beneficial for male teenagers seeking attention for pubertal delay to prevent psychosocial distress. While watchful waiting is appropriate for boys aged 12-14 with suspected constitutional delay of growth and puberty, hormone replacement should not be delayed beyond the age of 14. Hormone replacement should be proposed by the age of 12 when hypogonadism is diagnosed. Testosterone replacement is the standard treatment, but aromatase inhibitors have emerged as an interesting alternative. Gonadotrophin therapy appears more physiological for patients with central hypogonadism, but its efficacy and timing still need further research.

EXPERT OPINION ON PHARMACOTHERAPY (2022)

Review Biochemistry & Molecular Biology

Anti-Mullerian Hormone and Polycystic Ovary Syndrome in Women and Its Male Equivalent

Nathalie di Clemente, Chrystele Racine, Rodolfo A. Rey

Summary: This article reviews the main findings on anti-Mullerian hormone (AMH) and its involvement in the pathogenesis of polycystic ovary syndrome (PCOS) and its male equivalent. AMH has important roles in ovarian reserve, follicular development, and the differentiation of the genital tract. It is also used to assess Sertoli cell function in children and has potential implications for male fertility.

BIOMEDICINES (2022)

Editorial Material Endocrinology & Metabolism

Taming Idiopathic Central Precocious Puberty: High Frequency of Imprinting Disorders in Familial Forms

Lourdes Correa Brito, Rodolfo A. Rey

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2023)

Article Health Care Sciences & Services

Identification of a Novel Variant in Myelin Regulatory Growth Factor by Next-Generation Sequencing Led to the Detection of a Clinically Inapparent Congenital Heart Defect in a Patient with a 46,XY Disorder of Sex Development

Lourdes Correa Brito, Romina P. Grinspon, Jimena Lopez Dacal, Paula Scaglia, Maria Esnaola Azcoiti, Agustin Izquierdo, Maria Gabriela Ropelato, Rodolfo A. Rey

Summary: This study reported a case of a patient with 46,XY disorders of sex development (DSDs) in whom a novel variant in MYRF gene was identified, leading to the detection of a clinically inapparent congenital heart defect.

JOURNAL OF PERSONALIZED MEDICINE (2023)

Meeting Abstract Endocrinology & Metabolism

Ovarian AMH production is transiently affected in pubertal and prepubertal girls with acute lymphoblastic leukaemia and non-Hodgkin lymphoma receiving chemotherapy: a prospective, longitudinal study

Jimena C. Lopez Dacal, Silvina Prada, Marcela E. Gutierrez, Patricia Bedecarras, M. Gabriela Ropelato, Andrea Arcari, M. Gabriela Ballerini, Mirta Gryngarten, Marcela Soria, Lorena Moran, Cristina Ferraro, Analia Freire, Ignacio Bergada, Guillermo Drelichman, Luis Aversa, Rodolfo A. Rey, Romina P. Grinspon

HORMONE RESEARCH IN PAEDIATRICS (2021)

No Data Available